DR. MICHAEL GALEN CHAN, M.D.
Radiology at Arbor Dr, San Diego, CA
License number
California A110820
Category
Radiology
Type
Diagnostic Radiology
Address
Address
200 W Arbor Dr DEPARTMENT RADIOLOGY, San Diego, CA 92103
Phone
(619) 663-8882
Personal information
See more information about MICHAEL GALEN CHAN at radaris.comName
Address
Phone
4520 Eureka Ave, Yorba Linda, CA 92886
4600 Guava Ave, Seal Beach, CA 90740
4827 Mendocino Ter, Fremont, CA 94555
430 Harkness Ave, San Francisco, CA 94134
402 E Gutierrez St, Santa Barbara, CA 93101
Professional information
Tgg Accounting - Helping Business Make Better Decisions
Position:
Staff Assistant at TGG Accounting
Location:
Greater San Diego Area
Industry:
Accounting
Work:
TGG Accounting
- 10188 Telesis Court, San Diego, CA since Sep 2012
-
Staff Assistant
Motonation
- 10225 Prospect Ave., Santee, CA, 92071 May 2012 - Sep 2012
-
Accounting Intern
Tzu Chi Collegiate Association UCSD
Sep 2011 - Jun 2012
-
Public Relations Officer
Express to Success
Jul 2009 - Jun 2010
-
Peer Educator Intern
OceanView Terrace
Oct 2008 - Mar 2010
-
Student Worker
Education:
University of California, San Diego 2008 - 2012
Bachelor of Science, Management Science, Accounting
Bachelor of Science, Management Science, Accounting
Languages:
Chinese, English
Awards:
San Diego Business Journal Awards - TGG:
- 2012 Fastest Growing Companies List, #10 - 2012 Best Places to Work - Finalist - 2011 Fastest Growing Companies List, #17 - 2011 Best Places to Work - Finalist
- 2012 Fastest Growing Companies List, #10 - 2012 Best Places to Work - Finalist - 2011 Fastest Growing Companies List, #17 - 2011 Best Places to Work - Finalist
Dr. Michael G Chan, San Diego CA - MD (Doctor of Medicine)
Specialties:
Vascular & Interventional Radiology
Address:
200 W Arbor Dr, San Diego 92103
Languages:
English
Hospitals:
200 W Arbor Dr, San Diego 92103
UCSD Medical Center - Hillcrest
200 West Arbor Dr, San Diego 92103
UCSD Medical Center - Hillcrest
200 West Arbor Dr, San Diego 92103
Education:
Medical School
University of California At San Diego
Graduated: 2008
University of California At San Diego
Graduated: 2008
Michael Galen Chan, San Diego CA
Specialties:
Radiologist
Address:
200 W Arbor Dr, San Diego, CA 92103
Student At California Polytechnic State University-San Luis Obispo
Location:
Greater San Diego Area
Industry:
Mechanical or Industrial Engineering
Education:
California Polytechnic State University-San Luis Obispo 1997 - 2001
Uses Of Phospholipid Conjugates Of Synthetic Tlr7 Agonists
US Patent:
2013020, Aug 8, 2013
Filed:
Apr 29, 2011
Appl. No.:
13/695385
Inventors:
Dennis A. Carson - La Jolla CA, US
Howard B. Cottam - Escondido CA, US
Tomoko Hayashi - San Diego CA, US
Michael Chan - San Diego CA, US
Christina C.N. Wu - Escondido CA, US
Howard B. Cottam - Escondido CA, US
Tomoko Hayashi - San Diego CA, US
Michael Chan - San Diego CA, US
Christina C.N. Wu - Escondido CA, US
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
A61K 39/39, C07F 9/6561
US Classification:
4241841
Abstract:
The invention provides uses for phospholipid conjugates of TLR agonists, for instance in vaccines, and to prevent, inhibit or treat a variety of disorders including inflammation, cancer and pathogen, e.g., microbe, infection.
Toll-Like Receptor Modulators And Treatment Of Diseases
US Patent:
2010021, Aug 19, 2010
Filed:
Feb 11, 2010
Appl. No.:
12/704343
Inventors:
Dennis A. Carson - La Jolla CA, US
Howard B. Cottam - Escondido CA, US
Tomoko Hayashi - San Diego CA, US
Michael Chan - San Diego CA, US
Howard B. Cottam - Escondido CA, US
Tomoko Hayashi - San Diego CA, US
Michael Chan - San Diego CA, US
Assignee:
Regents of the University of California, San Diego - La Jolla CA
International Classification:
A61K 31/522, C07D 473/04, C07F 9/6558, A61K 31/688, C07F 9/6524, A61K 31/685, A61K 31/52, A61P 29/00, A61P 37/06
US Classification:
514 81, 544270, 5142632, 544244, 544269, 51426322, 544271, 5142631
Abstract:
Provided herein are small molecule conjugates that are agonists or antagonists of one or more toll-like receptors.
Tlr Agonists
US Patent:
2013016, Jun 27, 2013
Filed:
Nov 20, 2012
Appl. No.:
13/682208
Inventors:
Dennis A. Carson - La Jolla CA, US
Howard B. Cottam - Escondido CA, US
Michael Chan - San Diego CA, US
Christina C.N. Wu - Escondido CA, US
Suzanne Grimshaw - Poway CA, US
Howard B. Cottam - Escondido CA, US
Michael Chan - San Diego CA, US
Christina C.N. Wu - Escondido CA, US
Suzanne Grimshaw - Poway CA, US
Assignee:
The Regents of The University of California - Oakland CA
International Classification:
C07D 473/34
US Classification:
5142632, 544276, 51426337
Abstract:
The present invention provides for TLR agonist conjugates (compounds) and compositions, as well as methods of using them. The compounds of the invention are broad-spectrum, long-lasting, and non-toxic combination of synthetic immunostimulatory agents, which are useful for activating the immune system of a mammal, preferably a human and can help direct the pharmacophore to the receptor within the endosomes of target cells and enhance the signal transduction induced by the pharmacophore.
Tlr Agonists
US Patent:
2009032, Dec 31, 2009
Filed:
Aug 21, 2006
Appl. No.:
12/064529
Inventors:
Dennis A. Carson - La Jolla CA, US
Kenji Takabayshi - Poway CA, US
Suzanne Grimshaw - Poway CA, US
Howard B. Cottam - Escondido CA, US
Michael Chan - San Diego CA, US
Christina C.N. Wu - Escondido CA, US
Kenji Takabayshi - Poway CA, US
Suzanne Grimshaw - Poway CA, US
Howard B. Cottam - Escondido CA, US
Michael Chan - San Diego CA, US
Christina C.N. Wu - Escondido CA, US
Assignee:
The Regents of The University of California Office of Technology Transfer - Oakland CA
International Classification:
A61K 45/00, C07D 473/00, A61K 31/522, C12N 1/20, C12N 7/00, A61P 35/00
US Classification:
424 934, 544276, 51426337, 4352525, 4352521, 4352528, 4352351, 424 935, 424 936
Abstract:
The present invention provides for TLR agonist conjugates (compounds) and compositions, as well as methods of using them. The compounds of the invention are broad-spectrum, long-lasting, and non-toxic combination of synthetic immunostimulatory agents, which are useful for activating the immune system of a mammal, preferably a human and can help direct the pharmacophore to the receptor within the endosomes of target cells and enhance the signal transduction induced by the pharmacophore.